| Ovarian cancer in the era of immune checkpoint inhibitors: state of the art and future perspectives BA Maiorano, MFP Maiorano, D Lorusso, E Maiello Cancers 13 (17), 4438, 2021 | 65 | 2021 |
| Immunological backbone of uveal melanoma: is there a rationale for immunotherapy? E Rossi, G Schinzari, IG Zizzari, BA Maiorano, MM Pagliara, ... Cancers 11 (8), 1055, 2019 | 47 | 2019 |
| Dabrafenib and trametinib in BRAF mutant metastatic conjunctival melanoma E Rossi, BA Maiorano, MM Pagliara, MG Sammarco, T Dosa, M Martini, ... Frontiers in Oncology 9, 232, 2019 | 41 | 2019 |
| Conjunctival melanoma: genetic and epigenetic insights of a distinct type of melanoma E Rossi, G Schinzari, BA Maiorano, MM Pagliara, A Di Stefani, E Bria, ... International Journal of Molecular Sciences 20 (21), 5447, 2019 | 40 | 2019 |
| Efficacy of immune checkpoint inhibitors in different types of melanoma E Rossi, G Schinzari, BA Maiorano, G Indellicati, A Di Stefani, ... Human vaccines & immunotherapeutics 17 (1), 4-13, 2021 | 36 | 2021 |
| The interplay between PARP inhibitors and immunotherapy in ovarian cancer: the rationale behind a new combination therapy BA Maiorano, D Lorusso, MFP Maiorano, D Ciardiello, P Parrella, ... International Journal of Molecular Sciences 23 (7), 3871, 2022 | 30 | 2022 |
| Addition of androgen receptor-targeted agents to androgen-deprivation therapy and docetaxel in metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis BA Maiorano, U De Giorgi, G Roviello, C Messina, A Altavilla, C Cattrini, ... ESMO open 7 (5), 100575, 2022 | 27 | 2022 |
| How immunotherapy modified the therapeutic scenario of endometrial cancer: a systematic review BA Maiorano, MFP Maiorano, G Cormio, A Maglione, D Lorusso, ... Frontiers in Oncology 12, 844801, 2022 | 27 | 2022 |
| Targeting KRASG12C in colorectal cancer: The beginning of a new era D Ciardiello, BA Maiorano, E Martinelli ESMO open 8 (1), 100745, 2023 | 25 | 2023 |
| Activity and safety of immune checkpoint inhibitors in neuroendocrine neoplasms: a systematic review and meta-analysis A Bongiovanni, BA Maiorano, I Azzali, C Liverani, M Bocchini, V Fausti, ... Pharmaceuticals 14 (5), 476, 2021 | 24 | 2021 |
| Immune-checkpoint inhibitors in advanced bladder cancer: seize the day BA Maiorano, U De Giorgi, D Ciardiello, G Schinzari, A Cisternino, ... Biomedicines 10 (2), 411, 2022 | 23 | 2022 |
| Cancer vaccines for genitourinary tumors: recent progresses and future possibilities BA Maiorano, G Schinzari, D Ciardiello, MG Rodriquenz, A Cisternino, ... Vaccines 9 (6), 623, 2021 | 22 | 2021 |
| Olaparib and advanced ovarian cancer: Summary of the past and looking into the future BA Maiorano, MFP Maiorano, E Maiello Frontiers in Pharmacology 14, 1162665, 2023 | 19 | 2023 |
| Insights into the role of gut and intratumor microbiota in pancreatic ductal adenocarcinoma as new key players in preventive, diagnostic and therapeutic perspective C Panebianco, D Ciardiello, A Villani, BA Maiorano, TP Latiano, E Maiello, ... Seminars in Cancer Biology 86, 997-1007, 2022 | 18 | 2022 |
| Immunotherapy for biliary tract cancer in the era of precision medicine: current knowledge and future perspectives D Ciardiello, BA Maiorano, P Parente, MG Rodriquenz, TP Latiano, ... International Journal of Molecular Sciences 23 (2), 820, 2022 | 18 | 2022 |
| Biomarkers of response to advanced prostate cancer therapy R Iacovelli, C Ciccarese, G Schinzari, E Rossi, BA Maiorano, S Astore, ... Expert Review of Molecular Diagnostics 20 (2), 195-205, 2020 | 18 | 2020 |
| Efficacy and safety of PARP inhibitors in elderly patients with advanced ovarian cancer: a systematic review and meta-analysis BA Maiorano, MFP Maiorano, D Lorusso, M Di Maio, E Maiello International Journal of Gynecologic Cancer 32 (11), 2022 | 17 | 2022 |
| Immunotherapy in advanced anal cancer: Is the beginning of a new era? D Ciardiello, LP Guerrera, BA Maiorano, P Parente, TP Latiano, ... Cancer Treatment Reviews 105, 102373, 2022 | 17 | 2022 |
| Enfortumab vedotin in metastatic urothelial carcinoma: the solution EVentually? BA Maiorano, M Catalano, E Maiello, G Roviello Frontiers in Oncology 13, 1254906, 2023 | 16 | 2023 |
| Clinical efficacy of sequential treatments in KRASG12C-mutant metastatic colorectal cancer: findings from a real-life multicenter Italian study (CRC-KR GOIM) D Ciardiello, C Chiarazzo, V Famiglietti, A Damato, C Pinto, MG Zampino, ... ESMO open 7 (5), 100567, 2022 | 13 | 2022 |
Giovanni SchinzariUniversità Cattolica del Sacro CuoreEmail verificata su unicatt.it
